Citations

Institution: Mayo Clinic Clear

Showing 10 of 108152 citations.

Blaming the Right Fluorescent in Situ Hybridization
Warsame, Rahma , Dispenzieri, Angela , Dispenzieri, Angela

Journal of Clinical Oncology | September 1, 2015 | Volume: 33 | Issue: 33 | Pages: 3976-3976

10.1200/jco.2015.62.3876 | PMID 26324369 Get It

Mechanism by Which Caloric Restriction Improves Insulin Sensitivity in Sedentary Obese Adults
Distelmaier, Klaus, Lanza, Ian R. , Irving, Brian A. , Konopka, Adam R. , Shulman, Gerald I. , Johnson, Matthew L. , Robinson, Matthew M. , Nair, K. Sreekumaran , Shulman, Gerald I , Lanza, Ian R , Konopka, Adam R

Diabetes | August 31, 2015 | Volume: 65 | Issue: 1 | Pages: 74-84

10.2337/db15-0675 | PMID 26324180 Get It

Caloric restriction (CR) improves insulin sensitivity and reduces the incidence of diabetes in obese individuals. The underlying mechanisms whereby CR improves insulin sensitivity are not clear. We evaluated the effect of 16 weeks of CR on whole-body insulin sensitivity by pancreatic clamp before and after CR in 11 obese participants (BMI = 35 kg/m2) compared with 9 matched control subjects (BMI = 34 kg/m2). Compared with the control subjects, CR increased the glucose infusion rate needed to maintain euglycemia during hyperinsulinemia, indicating enhancement of peripheral insulin sensitivity. This improvement in insulin sensitivity was not accompanied by changes in skeletal muscle mitochondrial oxidative capacity or oxidant emissions, nor were there changes in skeletal muscle ceramide, diacylglycerol, or amino acid metabolite levels. However, CR lowered insulin-stimulated thioredoxin-interacting protein (TXNIP) levels and enhanced nonoxidative glucose disposal. These results support a role for TXNIP in mediating the improvement in peripheral insulin sensitivity after CR.
Transport proteins NHA1 and NHA2 are essential for survival, but have distinct transport modalities
Chintapalli, Venkateswara R., Kato, Akira , Hirata, Taku, Woods, Debra J., Overend, Gayle , Davies, Shireen A. , Romero, Michael F. , Dow, Julian A. T. , Henderson, Louise, Dow, Julian A T , Romero, Michael F , Kato, Akira

Proceedings of the National Academy of Sciences | August 31, 2015 | Volume: 112 | Issue: 37 | Pages: 11720-11725

10.1073/pnas.1508031112 | PMID 26324901 Get It

Significance Cation/proton antiporters (CPAs) are essential to life. The sodium/proton exchanger (NHE) branch of the CPA family has been studied exhaustively and is an important drug target; however, much less is known about the recently discovered NHA branch, represented by two genes in both humans and flies. Here we show that sodium/hydrogen antiporter (NHA) function is essential to life, and that both NHAs protect against salt stress. Their transport mechanisms are radically different, however, suggesting that function cannot be inferred from structural similarity. Although NHA2 was found to be a Na + /H + exchanger as expected, NHA1 was seen to act as an electroneutral H + /Cl - cotransporter. This is an important finding for future studies of these transporters.
Clinical and Translational Results of a Phase II, Randomized Trial of an Anti–IGF-1R (Cixutumumab) in Women with Breast Cancer That Progressed on Endocrine Therapy
Gradishar, William J. , Sparano, Joseph A. , Chuang, Ellen, Northfelt, Donald W. , Schwartz, Gary N. , Youssoufian, Hagop , Tang, Shande, Novosiadly, Ruslan D., Forest, Amélie, Nguyen, Tuan S., Cosaert, Jan , Grebennik, Dmitri, Haluska, Paul , Yardley, Denise Aysel , Layman, Rachel M. , Sparano, Joseph A

Clinical Cancer Research | August 31, 2015 | Volume: 22 | Issue: 2 | Pages: 301-309

10.1158/1078-0432.ccr-15-0588 | PMID 26324738 Get It

Abstract Purpose: This phase II trial evaluated the efficacy and safety of cixutumumab, a human anti–insulin-like growth factor receptor 1 (IGF-1R) monoclonal IgG1 antibody, and explored potential biomarkers in postmenopausal women with hormone receptor–positive breast cancer. Experimental Design: Patients with hormone receptor–positive breast cancer that progressed on antiestrogen therapy received (2:1 randomization) cixutumumab 10 mg/kg and the same antiestrogen (arm A) or cixutumumab alone (arm B) every 2 weeks (q2w). Primary endpoint was progression-free survival (PFS); secondary endpoints included overall survival (OS) and safety. Correlative analyses of IGF-1R, total insulin receptor (IR), and IR isoforms A (IR-A) and B (IR-B) expression in tumor tissue were explored. Results: Ninety-three patients were randomized (arm A, n = 62; arm B, n = 31). Median PFS was 2.0 and 3.1 months for arm A and arm B, respectively. Secondary efficacy measures were similar between the arms. Overall, cixutumumab was well tolerated. IGF-1R expression was not associated with clinical outcomes. Regardless of the treatment, lower IR-A, IR-B, and total IR mRNA expression in tumor tissue was significantly associated with longer PFS [IR-A: HR, 2.62 (P = 0.0062); IR-B: HR, 2.21 (P = 0.0202); and total IR: HR, 2.18 (P = 0.0230)] and OS [IR-A: HR, 2.94 (P = 0.0156); IR-B: HR, 2.69 (P = 0.0245); and total IR: HR, 2.72 (P = 0.0231)]. Conclusions: Cixutumumab (10 mg/kg) with or without antiestrogen q2w had an acceptable safety profile, but no significant clinical efficacy. Patients with low total IR, IR-A, and IR-B mRNA expression levels had significantly longer PFS and OS, independent of the treatment. The prognostic or predictive value of IR as a biomarker for IGF-1R–targeted therapies requires further validation. Clin Cancer Res; 22(2); 301–9. ©2015 AACR.
Noninvasive Prenatal Genetic Testing: Current and Emerging Ethical, Legal, and Social Issues
Minear, Mollie , Alessi, Stephanie A., Allyse, Megan , Michie, Marsha , Chandrasekharan, Subhashini , Allyse, Megan A

Annual Review of Genomics and Human Genetics | August 31, 2015 | Volume: 16 | Issue: 1 | Pages: 369-398

10.1146/annurev-genom-090314-050000 | PMID 26322648 Get It

Noninvasive prenatal genetic testing (NIPT) for chromosomal aneuploidy involving the analysis of cell-free fetal DNA became commercially available in 2011. The low false-positive rate of NIPT, which reduces unnecessary prenatal invasive diagnostic procedures, has led to broad clinician and patient adoption. We discuss the ethical, legal, and social issues raised by rapid and global dissemination of NIPT. The number of women using NIPT is anticipated to expand, and the number of conditions being tested for will continue to increase as well, raising concerns about the routinization of testing and negative impacts on informed decision making. Ensuring that accurate and balanced information is available to all pregnant women and that access to NIPT is equitable will require policy guidance from regulators, professional societies, and payers. Empirical evidence about stakeholders' perspectives and experiences will continue to be essential in guiding policy development so that advances in NIPT can be used effectively and appropriately to improve prenatal care.
Radiologic-Pathologic Correlation: Metastatic Pulmonary Epithelioid Hemangioendothelioma of Bone Primary
Lee, Christine U. , Zreik, Riyam , Boland, Jennifer M. , White, Mariah L., Zreik, Riyam T

Journal of Clinical Imaging Science | August 31, 2015 | Volume: 5 | Issue: No issue available | Pages: 50

10.4103/2156-7514.163994 | PMID 26430543 Get It

Epithelioid hemangioendothelioma is a rare vascular malignancy often characterized by a clinically indolent course and delayed diagnosis. The authors present the radiologic and pathologic features of a case of pulmonary epithelioid hemangioendothelioma which was initially thought to be calcified granulomas.
Platelets in the pathogenesis of acute respiratory distress syndrome
Yadav, Hemang , Kor, Daryl J.

American Journal of Physiology-Lung Cellular and Molecular Physiology | August 29, 2015 | Volume: 309 | Issue: 9 | Pages: L915-L923

10.1152/ajplung.00266.2015 | PMID 26320157 Get It

Platelets have an emerging and incompletely understood role in a myriad of host immune responses, extending their role well beyond regulating thrombosis. Acute respiratory distress syndrome is a complex disease process characterized by a range of pathophysiologic processes including oxidative stress, lung deformation, inflammation, and intravascular coagulation. The objective of this review is to summarize existing knowledge on platelets and their putative role in the development and resolution of lung injury.
Fatigue, dyspnea, and intermittent symptoms are associated with treatment-seeking delay for symptoms of atrial fibrillation before diagnosis
McCabe, Pamela J. , Rhudy, Lori M. , Chamberlain, Alanna M. , DeVon, Holli A. , Chamberlain, Alanna M

European Journal of Cardiovascular Nursing | August 29, 2015 | Volume: 15 | Issue: 6 | Pages: 459-468

10.1177/1474515115603901 | PMID 26318825 Get It

Lateral Tibial Posterior Slope Is Increased in Patients With Early Graft Failure After Anterior Cruciate Ligament Reconstruction
Christensen, Joshua J., Krych, Aaron J. , Engasser, William M. , Vanhees, Matthias , Collins, Mark S., Dahm, Diane L., Krych, Aaron J

The American Journal of Sports Medicine | August 28, 2015 | Volume: 43 | Issue: 10 | Pages: 2510-2514

10.1177/0363546515597664 | PMID 26320223 Get It

Background: The lateral tibial posterior slope (LTPS) has been reported in multiple studies to correlate with an increased risk for native anterior cruciate ligament (ACL) tearing. To date, no study has examined the effect of an increased LTPS as measured on magnetic resonance imaging (MRI) on the likelihood of ACL graft failure. Hypothesis: An increased LTPS as measured on MRI would correlate with an increased risk for ACL graft failure. Study Design: Case-control study; Level of evidence, 3. Methods: Fifty-eight patients were initially identified who experienced graft failure after primary ACL reconstruction and underwent revision between 1998 and 2009. Exclusion criteria were clinical follow-up of less than 4 years, graft failure occurring greater than 2 years after primary surgery, skeletal immaturity, deep infection, lack of available preoperative MRI, and history of trauma to the proximal tibia. This left 35 patients with early (within 2 years) failure of primary ACL reconstruction. These patients were matched to 35 control participants who had undergone ACL reconstruction with a minimum of 4 years of clinical follow-up and no evidence of graft failure. Patients were matched by age, sex, date of primary surgery, and graft type. The LTPS was then determined on MRI in a blinded fashion. Results: The mean time to failure in patients in the study group was 1 year (range, 0.6-1.4 years). The mean follow-up of those in the matched control group was 6.9 years (range, 4.0-13.9 years). The mean LTPS in the early ACL failure group was found to be 8.4°, which was significantly larger than that in the control group at 6.5° ( P = .012). The odds ratio for graft failure considering a 2° increase in the LTPS was 1.6 (95% CI, 1.1-2.2) and continued to increase to 2.4 (95% CI, 1.2-5.0) and 3.8 (95% CI, 1.3-11.3) with 4° and 6° increases in the LTPS, respectively. No significant association was identified between graft type and graft failure. Conclusion: An increased LTPS is associated with an increased risk for early ACL graft failure, regardless of graft type. Orthopaedic surgeons should consider measuring the LTPS as part of the preoperative assessment of ACL-injured patients.
Mesenchymal Stromal Cells Improve Renovascular Function in Polycystic Kidney Disease
Franchi, Federico , Peterson, Karen M. , Xu, Rende, Miller, Brent S., Psaltis, Peter J. , Harris, Peter C. , Lerman, Lilach O. , Rodriguez‐Porcel, Martin , Harris, Peter C

Cell Transplantation | August 28, 2015 | Volume: 24 | Issue: 9 | Pages: 1687-1698

10.3727/096368914x684619 | PMID 25290249 Get It

Polycystic kidney disease (PKD) is a common cause of end-stage renal failure, for which there is no accepted treatment. Progenitor and stem cells have been shown to restore renal function in a model of renovascular disease, a disease that shares many features with PKD. The objective of this study was to examine the potential of adult stem cells to restore renal structure and function in PKD. Bone marrow-derived mesenchymal stromal cells (MSCs, 2.5 × 10 5 ) were intrarenally infused in 6-week-old PCK rats. At 10 weeks of age, PCK rats had an increase in systolic blood pressure (SBP) versus controls (126.22 ± 2.74 vs. 116.45 ± 3.53 mmHg, p < 0.05) and decreased creatinine clearance (3.76 ± 0.31 vs. 6.10 ± 0.48 μl/min/g, p < 0.01), which were improved in PKD animals that received MSCs (SBP: 114.67 ± 1.34 mmHg, and creatinine clearance: 4.82 ± 0.24 μl/min/g, p = 0.001 and p = 0.003 vs. PKD, respectively). MSCs preserved vascular density and glomeruli diameter, measured using microcomputed tomography. PCK animals had increased urine osmolality (843.9 ± 54.95 vs. 605.6 ± 45.34 mOsm, p < 0.01 vs. control), which was improved after MSC infusion and not different from control (723.75 ± 56.6 mOsm, p = 0.13 vs. control). Furthermore, MSCs reduced fibrosis and preserved the expression of proangiogenic molecules, while cyst size and number were unaltered by MSCs. Delivery of exogenous MSCs improved vascular density and renal function in PCK animals, and the benefit was observed up to 4 weeks after a single infusion. Cell-based therapy constitutes a novel approach in PKD.